High platelet-to-lymphocyte ratio is associated with poor prognosis in patients with unresectable intrahepatic cholangiocarcinoma receiving gemcitabine plus cisplatin

High platelet-to-lymphocyte ratio is associated with poor prognosis in patients with unresectable intrahepatic cholangiocarcinoma receiving gemcitabine plus cisplatin

Abstract Background Several systemic inflammatory response (SIR) markers, including platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), and albumin-to-globulin ratio (AGR), have emerged as prognostic markers in various cancers. The aim of thi...

Full description

Bibliographic Details
Main Authors: Gunn Huh, Ji Kon Ryu, Jung Won Chun, Joo Seong Kim, Namyoung Park, In Rae Cho, Woo Hyun Paik, Sang Hyub Lee, Yong-Tae Kim
Format: Article
Language:English
Published: BMC 2020-09-01
Series:BMC Cancer
Subjects:
Intrahepatic cholangiocarcinoma
Platelet-to-lymphocyte ratio
Overall survival
Online Access:http://link.springer.com/article/10.1186/s12885-020-07390-3

Internet

http://link.springer.com/article/10.1186/s12885-020-07390-3

Similar Items